
    
      A 3-Dose, Multicenter, Randomized, Double-Masked, Crossover Phase 2 Safety and Efficacy Study
      of BRIMOCHOL™ Topical Ophthalmic Solution vs. BRIMOCHOL™ F Topical Ophthalmic Solution vs.
      Monotherapy with Carbachol Topical Ophthalmic Solution in Subjects with Emmetropic Phakic and
      Pseudophakic Presbyopia
    
  